Back
Fu Shou Yuan International Group Ltd. 10K Form
Sell
29
FSHUF
Fu Shou Yuan International Group Ltd.
Last Price:
$0.38
Seasonality Move:
-6.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FSHUF News And Ratings
See the #1 stock for the next 7 days that we like better than FSHUF
FSHUF Financial Statistics
Sales & Book Value
| Annual Sales: | $288.7M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 19.87 |
| Annual Sales: | $0.34 |
| Price / Book: | 1.49 |
Profitability
| EPS (TTM): | -0.01140 |
|---|---|
| Net Income (TTM): | $-17.7M |
| Gross Margin: | $157.6M |
| Return on Equity: | 5.76% |
| Return on Assets: | 4.38% |
Fu Shou Yuan International Group Ltd. Earnings Forecast
Key Fu Shou Yuan International Group Ltd. Financial Ratios
-
The Gross Profit Margin over the past 15 years for FSHUF is 54.60%.
-
The Selling, General & Administrative Expenses for FSHUF have been equal to 13.77% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 3.30% of Operating Income.
-
The Net Earning history of FSHUF is 23.94% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 10 years.
Fu Shou Yuan International Group Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Diversified Consumer Services |
| Sector: | Consumer Discretionary |
| Current Symbol: | FSHUF |
| Website: | fsygroup.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 3.06 |
| Quick Ratio: | 2.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 16.67 |
|---|---|
| Forward P/E Ratio: | 0 |
FSHUF Technical Analysis vs Fundamental Analysis
Sell
29
Fu Shou Yuan International Group Ltd. (FSHUF)
is a Sell
Is Fu Shou Yuan International Group Ltd. a Buy or a Sell?
-
Fu Shou Yuan International Group Ltd. stock is rated a SellThe current Fu Shou Yuan International Group Ltd. [FSHUF] share price is $0.38. The Score for FSHUF is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.